Abstract
Background:Clostridium difficile has been shown to be a nosocomial infection associated with diarrhoea and pseudomembranous colitis in hospitalized patients especially old patients. In my previous studies, it was shown the occurrence of C. difficile in animals feces and vegetables which may act as a source of infection to humans.
The aim of the study was to determine the prevalence of C. difficile in retail raw cow, sheep, and goat, meat in Jazan, Saudi Arabia.
Method: A total of 600 raw meat samples from cow, sheep, and goat were collected during June–December 2015, and tested for the presence of C. difficile. The method used to check for the presence of C. difficile was by choosing selective enrichment media in C. difficile broth, followed by alcohol shock-treatment and plating onto C. difficile selective medium. C. difficile isolates were typed using PCR ribotyping and also analyzed for antibiotic susceptibility.
Results: It was shown that, 9 of 600 meat samples (1.5%) were contaminated with C. difficile. The prevalence of C. difficile was as follow: 7 out of 600 (1.17%) were found in cow, 2 out of 600 (0.3%) were found in sheep, while was no C. difficile was isolated from goat. Eleven out of 18 C. difficile isolates were positive for tcdA, tcdB and cdtB toxin genes and were classified as ribotype 078. Three strains were positive tcdA, and tcdB, and two strains possessed only tcdB. C. difficile strains showed high resistance to ampicillin, gentamycin, erythromycin and nalidixic acid.
Conclusions: The present work shows the potential risk of raw meet in transmitting C. difficile to humans.
Keywords: Clostridium difficile, Raw meat, Cow, Sheep
1. Background
Clostridium difficile is a Gram-positive, anaerobic bacterium. For the last few years, C. difficile infection has become a major cause of nosocomial infection. Although it is known as health-care infection, the incidence of community-acquired infections has increased recently, such as infirmary (McFarland et al., 2007). Notably, there is a clue that C. difficile may be transmitted to the healthcare by asymptomatic carriers (Clabots et al., 1992). There are reports about the asymptomatic carriers of C. difficile in healthy people which vary from low percent 0–3% in Europe to a high percent which is 15% in Japan (Mulligan, 2008). Up to date a small amount of knowledge is known about the prevalence of C. difficile in the community and the possible way of transmission to humans.
C. difficile was found in many sources, including food, soil, water, and animal feces (Rodriguez-Palacios, 2007, Al Saif and Brazier, 1996) and this could suggest the possible way of transmission to human. Salmonella species and Escherichia coli O157 were implicated in food infections (Sagoo et al., 2003, Delaquis et al., 2007).
We have shown earlier the prevalence of C. difficile in ready to eat salads distributed in the markets in UK (Bakri et al., 2009) and it was the first study world-wide isolating C. difficile from ready to eat salads. In this study we are trying expand the search to find another source of C. difficile transmission to human.
The prevalence of C. difficile transmission from animals to human is not known in Saudi Arabia especially in Jazan province. The aim of this study was to determine the prevalence of C. difficile in raw cow, sheep, goat, and camel meat in Jazan, Saudi Arabia.
2. Methods
2.1. Sample collection
A total of 600 raw meat samples were collected between June and December 2015. The number of samples collected from each animal was 200 samples from cow, 200 samples from sheep, and 200 samples from goat. The samples were purchased from different shops in meat market in Jazan, Saudi Arabia. Each sample was purchased, placed in sterile bag, and immediately taken to the laboratory for processing.
2.2. Isolation and identification of C. difficile
On arrival, the samples were processed immediately using aseptic techniques. The method for detection used was based on the method described by Rodriguez-Palacios et al. Rodriguez-Palacios (2007). In brief, 5 g of each sample was transferred to 20 mL of C. difficile broth (CDB; Oxoid SR0048) containing 40 g/l proteose peptone, 5.0 g/l, disodium hydrogen phosphate, 0.1 g/l magnesium sulfate, 2.0 g/l sodium chloride, 6.0 g/l fructose and 1.0 g/l sodium taurocholate supplemented with C. difficile selective supplement (Oxoid, UK, Code: SR0173) and 5% (v/v) defibrinated sheep blood. After incubation at 37 °C for 10–15 days under anaerobic conditions 2 mL of the enrichment broth was added to 2 mL of 96% ethanol in a centrifuge tube and homogenized for 50 min on a shaker at room temperature. After centrifugation (3800g for 10 min), a loopful of the sediment was streaked onto C. difficile agar base (Oxoid, UK, Code: CM0601) supplemented with an antibiotic supplement for the selective isolation of C. difficile (Oxoid, UK, Code: SR0173) and 7% (v/v) defibrinated sheep blood and the plates were incubated for 48 h at 37 °C, under anaerobic conditions. Three colonies per plate were subcultured onto tryptone soya agar (Oxoid, UK, Code: CM0131) and tested by standard microbiological and biochemical procedures including odor, Gram stain morphology and L-proline.
Crudely extracted DNA (boiling for 10 min) was used for PCR confirmation (housekeeping tpi gene detection), and determination of toxin gene (tcdA, tcdB and cdtB) of isolates as performed in previous studies.
Antimicrobial susceptibility testing:
Antimicrobial susceptibility analysis was conducted by using Kirby–Bauer disk diffusion method using Mueller–Hinton agar as described by Rodriguez-Palacios (2007). In the present study we have tested the following antimicrobial agents: nalidixic acid (30 μg), ciprofloxacin (5 μg), erythromycin (15 μg), tetracycline (30 μg), doxycycline (30 μg), gentamicin (10 μg), metronidazol (5 μg), ampicillin (10 μg), chloramphenicol (30 μg), vancomycin (30 μg), Piperacillin-tazobactam (10 μg), Cefoxitin (15 μg) and clindamycin (2 μg). Inoculated plates were incubated at 37 °C for 48 h, under anaerobic conditions. The susceptibility of the C. difficile to each antimicrobial agent was measured and the results were interpreted as described by Clinical and Laboratory Standards Institute, 2007.
3. Results and discussion
The results show the prevalence of C. difficile isolated from cow, sheep, and goat meat in Jazan, Saudi Arabia (Table 1). 9 C. difficile isolates out of 600 meat samples were identified. There was a significant difference (P < 0.05) in the frequency of positive samples among the meat samples.
Table 1.
Type of sample | Number of samples | Number of C. difficile positive samples |
---|---|---|
Cow | 200 | 7 (3.5%) |
Sheep | 200 | 2 (1%) |
Goat | 200 | 0 |
Total | 600 | 9 (1.5%) |
The highest prevalence of C. difficile was found in cow meat samples (7 out of 200), followed by sheep (2 out of 200), and there were no C. difficile isolates were identified from goat (Table 1).
The difference in the number of C. difficile isolates between cows and sheep could be due to the fact that in our culture the farmers keep cows most of the time in a cowshed which is usually near to their houses. Moreover, farmers get in touch with cows on a daily basis to get the milk and this increase the chance of C. difficile transmission between human and cows. On the other hand, sheep usually leave the barn early morning and return in the evening which indicates there is less time compared to cows to be in touch with humans. Finally, goats usually live in mountains areas where they move freely with less contact with humans. This could explain the absence of C. difficile isolates from goat samples.
The source of C. difficile in meat samples is unclear. The source of C. difficile in meat samples could be the gastrointestinal tract of animals or due to cross contamination from the slaughters handling the meat (Keessen et al., 2011).
Eleven out of 18 C. difficile isolates were positive for tcdA, tcdB and cdtB toxin genes and were classified as ribotype 078. Three strains were positive tcdA, and tcdB, and two strains possessed only tcdB. The remaining two isolates were proved to be nontoxigenic. The majority of ribotype 078 is consistent with other studies of food animals and food (Indra et al., 2008). Presence C. difficile ribotype 078 strain in humans in the same region with CDI, attention must be given as the main source might be food. Yet, further research is needed to conclude whether food is rational source of this particular bacterial prevalence.
Antimicrobial susceptibility analysis results are shown in Table 2. C. difficile strains showed high resistance to ampicillin, gentamycin, erythromycin and nalidixic acid. Most of the C. difficile isolates were susceptible to metronidazole, chloramphenicol and vancomycin as was observed in other studies (Jöbstl et al., 2010). Metronidazole and vancomycin are the most regularly used drugs to treat C. difficile diarrhea patients but they are not used in animal’s food.
Table 2.
Antimicrobial agent | Sensitive | Intermediate | Resistant |
---|---|---|---|
Ampicillin | 2 (11.11) | 5 (16.67) | 13 (72.22) |
Chloramphenicol | 16 (88.89) | 2 (11.11) | 0 (0) |
Ciprofloxacin | 7 (38.89) | 6 (33.33) | 5 (27.78) |
Doxycycline | 8 (44.44) | 10 (55.56) | 0 (0) |
Clindamycin | 4 (22.22) | 8 (44.44) | 6 (33.33) |
Erythromycin | 3 (16.67) | 6 (33.33) | 9 (50.00) |
Gentamicin | 0 (0) | 3 (16.67) | 15 (83.33) |
Metronidazole | 17 (94.44) | 1 (5.56) | 0 (0) |
Nalidixic acid | 1 (5.56) | 3 (16.67) | 14 (77.78) |
Tetracycline | 8 (44.44) | 5 (27.78) | 5 (27.78) |
Vancomycin | 12 (83.33) | 3 (16.67) | 0 (0) |
Piperacillin-tazobactam | 4 (22.22) | 8 (44.44) | 6 (33.33) |
Cefoxitin | 9 (50.00) | 5 (27.78) | 4 (22.22) |
4. Conclusion
This is the first work done on C. difficile prevalence in animal meat in Jazan, Saudi Arabia. Our work shows the potential risk of meat, as a source of transmitting C. difficile to humans. The presence of blood and absence of cleaning in Slaughterhouses can be an excellent source for spreading infections. There is a high demand for good observation for slaughter hygiene, get rid of animal remnants in a healthy way, and implementation of good slaughtering practice.
Footnotes
Peer review under responsibility of King Saud University.
References
- Al Saif N., Brazier J.S. The distribution of Clostridium diffi cile in the environment of South Wales. J. Med. Microbiol. 1996;45:133–137. doi: 10.1099/00222615-45-2-133. [DOI] [PubMed] [Google Scholar]
- Bakri M., Brown D., Butcher J., Sutherland A. Clostridium difficile in ready-to-eat salads, Scotland. Emerg. Infect. Dis. 2009 May;15(5):817–818. doi: 10.3201/eid1505.081186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clabots C.R., Johnson S., Olson M.M., Peterson L.R., Gerding D.N. Acquisition of Clostridium diffi cile by hospitalized patients: evidence for colonized new admissions as a source of infection. J. Infect. Dis. 1992;166:561–567. doi: 10.1093/infdis/166.3.561. [DOI] [PubMed] [Google Scholar]
- Clinical and Laboratory Standards Institute (CLSI) CLSI document M11-A7. seventh ed. Clinical and Laboratory Standards Institute; Wayne, PA: 2007. Performance Standards for Antimicrobial Susceptibility Testing. [Google Scholar]
- Delaquis P., Bach S., Dinu L.D. Behavior of Escherichia coli O157:H7 in leafy vegetables. J. Food Prot. 2007;70:1966–1974. doi: 10.4315/0362-028x-70.8.1966. [DOI] [PubMed] [Google Scholar]
- Indra A., Schmid D., Huhulescu S., Hell M., Gattringer R., Hasenberger P., Fiedler A., Wewalka G., Allerberger F. Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006–2007. J. Med. Microbiol. 2008;57:702–708. doi: 10.1099/jmm.0.47476-0. [DOI] [PubMed] [Google Scholar]
- Jöbstl M., Heuberger S., Indra A., Nepf R., Köfer J., Wagner M. Clostridium difficile in raw products of animal origin. Int. J. Food Microbiol. 2010;138:172–175. doi: 10.1016/j.ijfoodmicro.2009.12.022. [DOI] [PubMed] [Google Scholar]
- Keessen E.C., Gaastra W., Lipman L.J.A. Clostridium difficile infection in humans and animals, differences and similarities. Vet. Microbiol. 2011;153:205–217. doi: 10.1016/j.vetmic.2011.03.020. [DOI] [PubMed] [Google Scholar]
- McFarland L.V., Beneda H.W., Clarridge J.E., Raugi G.J. Implications of the changing face of Clostridium diffi cile disease for health care practitioners. Am. J. Infect. Control. 2007;35:237–253. doi: 10.1016/j.ajic.2006.06.004. [DOI] [PubMed] [Google Scholar]
- Mulligan M.E. Academic Press; London: 2008. Clostridium Diffi Cile—Its Role in Intestinal Disease; pp. 229–256. [Google Scholar]
- Rodriguez-Palacios A., Staempfli H.R., Duffield T., Weese J.S. Clostridium diffi cile in retail ground meat, Canada. Emerg. Infect. Dis. 2007;13:485–487. doi: 10.3201/eid1303.060988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sagoo S.K., Little C.L., Ward L., Gillespie I.A., Mitchell R.T. Microbiological study of ready-to-eat salad vegetables from retail establishments uncovers a national outbreak of salmonellosis. J. Food Prot. 2003;66:403–409. doi: 10.4315/0362-028x-66.3.403. [DOI] [PubMed] [Google Scholar]